Spectral ai announces 2024 first quarter financial results

Q1 overview research & development revenue of $6.3 million improved capital structure reflected in cash of $10.2 million deepview ai®-burn devices deployed in uk; expect commercial revenue in 2h 2024 additional regulatory submissions in us and uk for deepview™ system expected in 2024 and 2025 dallas, may 07, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended march 31, 2024 (“q1 2024”) and provided an update on its ongoing business activities. “during the first quarter we continued to execute against our strategic priorities resulting in significant accomplishments across the enterprise,” said peter m.
MDAI Ratings Summary
MDAI Quant Ranking